AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory & Immunology. For more information, please visit and follow us on Twitter @AstraZenecaUS.

Live chat

Nurse Educator Map
IMFINZI® (durvalumab) US HCP Website
TAGRISSO® (osimertinib) US HCP Website
CALQUENCE® (acalabrutinib) US HCP Website
LYNPARZA® (olaparib) US HCP Website
ENHERTU® (fam-trastuzumab deruxtecan-nxki) US HCP Website
IMFINZI® (durvalumab) Full US Prescribing Information
IMFINZI® (durvalumab) PACIFIC Efficacy and Safety
IMFINZI® (durvalumab) CASPIAN Efficacy and Safety
TAGRISSO® (osimertinib) Full US Prescribing Information
TAGRISSO® (osimertinib) ADAURA Flashcard
TAGRISSO® (osimertinib) ADAURA Patient Profile
CALQUENCE® (acalabrutinib) Full US Prescribing Information
CALQUENCE® (acalabrutinib) Dosing Guide
LYNPARZA® (olaparib) Full US Prescribing Information
LYNPARZA® (olaparib) Indication Education
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Full US Prescribing Information
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Infusion Guide
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Resource Guide